Amneal Pharmaceuticals Joins S&P SmallCap 600 Index
I'm PortAI, I can summarize articles.
Amneal Pharmaceuticals Inc. will be added to the S&P SmallCap 600 Index, effective January 30, 2026. This inclusion is due to the company's strong operating and financial performance, meeting the index's criteria for market capitalization, liquidity, sector representation, and sustained profitability.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments